0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Human Health Effects Sign in to save

Elevated blood microplastics and their potential association with Parkinson’s disease

Journal of Hazardous Materials 2025 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count.
Zongtang Xu, Xingting Huang, Ziting Zhu, Fengchu Liang, Huimin Hu, Tingting Cai, Tianni Liu, Weiqing Huang, Lin Lü, Pingyi Xu, Wenlong Zhang

Summary

Researchers collected blood samples from 21 Parkinson's disease patients and 12 healthy controls and found that patients with Parkinson's had significantly higher levels of microplastics in their blood. The Parkinson's patients also reported more frequent use of disposable plastic products and bottled water, suggesting greater environmental exposure. The study provides early evidence of a potential association between blood microplastic levels and Parkinson's disease, though further research is needed to understand any causal relationship.

Body Systems
Models
Study Type In vitro

Microplastic (MP) contamination in human blood and its potential link to Parkinson's disease (PD) remain poorly understood. In this study, we collected whole blood samples from 21 PD patients and 12 age- and sex-matched healthy controls under strict anticontamination protocols. A lifestyle questionnaire was administered to assess MP exposure-related habits, revealing that PD patients reported more frequent use of disposable plastic products and bottled water consumption, suggesting greater environmental exposure. Pyrolysis-gas chromatography-mass spectrometry (Py-GC/MS), laser direct infrared imaging (LDIR) and scanning electron microscopy (SEM) were used to quantify and characterize the MPs. Five polymer types-polyethylene (PE), polystyrene (PS), polyvinyl chloride (PVC), polypropylene (PP) and nylon-66 (PA66)-were detected in the sample. The total MP burden was significantly greater in PD patients than in controls (21.36 ± 8.42 vs. 13.56 ± 5.92 μg/g; p < 0.01), with the greatest increases observed for PVC (1.49-fold), PP (2.74-fold) and PA66 (6.62-fold), whereas the PE and PS levels were not significantly different. LDIR and SEM analyses revealed diverse particle morphologies, with most polymers appearing as granular particles. In vitro assays further revealed that PVC and PP microplastics induced dopaminergic neuron apoptosis and increased the level of phosphorylated α-synuclein (p-α-syn), providing support for their potential neurotoxicity. Together, these findings indicate elevated blood MP levels in PD patients and offer preliminary evidence linking polymer exposure with PD-related neuronal vulnerability.

Share this paper